Shenouda Maged
Chief Financial Officer
Shenouda Maged has filed 3 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Sep 11, 2026.
On the most recent filing, Shenouda Maged is listed as Chief Financial Officer at RELMADA THERAPEUTICS, INC. Inside the rolling window, Shenouda Maged reported 4 open-market purchases totaling $2.0M in RLMD and no open-market sales. The largest disclosed transaction in the window is a purchase of 500,000 RLMD shares on Nov 5, 2025, worth $1.1M.
Companies traded
Other insiders at RLMD
Insider Buying
$2.0M
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Shenouda Maged made?
Shenouda Maged has filed 3 SEC Form 4 filings (4 transaction rows) across 1 company since 2025.
Which companies does Shenouda Maged trade?
Shenouda Maged has filed SEC Form 4 disclosures for 1 company, including RLMD.
When was Shenouda Maged's most recent SEC Form 4 filing?
Shenouda Maged's most recent SEC Form 4 filing on Tracefour is dated Sep 11, 2026.
What is Shenouda Maged's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Shenouda Maged is listed as Chief Financial Officer.
What is Shenouda Maged's total buy and sell value in the current window?
Inside the rolling retention window, Shenouda Maged bought $2.0M and sold $0 based on SEC Form 4 filings.
What was Shenouda Maged's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 500,000 RLMD shares on 2025-11-05, worth $1.1M, per SEC Form 4 filings.